Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-25
DOI
10.1245/s10434-020-09161-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
- (2019) Kaitlyn J. Kelly et al. ANNALS OF SURGICAL ONCOLOGY
- RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score
- (2019) A. Arjona-Sanchez et al. ANNALS OF SURGICAL ONCOLOGY
- Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study
- (2019) Nikhil V. Kotha et al. ANNALS OF SURGICAL ONCOLOGY
- Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization
- (2019) Marta Schirripa et al. CLINICAL CANCER RESEARCH
- Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
- (2019) Charlotte E L Klaver et al. Lancet Gastroenterology & Hepatology
- RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer
- (2019) Zoe Morgan et al. JOURNAL OF SURGICAL RESEARCH
- Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)
- (2019) Dario Baratti et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
- (2019) Wilhelm Graf et al. ANNALS OF SURGICAL ONCOLOGY
- Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
- (2018) Troels Dreier Christensen et al. ACTA ONCOLOGICA
- Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases
- (2018) I. Ubink et al. BRITISH JOURNAL OF SURGERY
- Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
- (2018) Dario Baratti et al. DISEASES OF THE COLON & RECTUM
- Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394).
- (2018) Diane Goere et al. JOURNAL OF CLINICAL ONCOLOGY
- The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis
- (2018) Julien Péron et al. SURGERY
- Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin
- (2018) Marcel André Schneider et al. ANNALS OF SURGERY
- First-line therapy for mCRC — the influence of primary tumour location on the therapeutic algorithm
- (2017) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer
- (2017) Fausto Petrelli et al. JAMA Oncology
- Toward the molecular dissection of peritoneal pseudomyxoma
- (2016) F. Pietrantonio et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases
- (2016) Riom Kwakman et al. ANNALS OF SURGERY
- Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
- (2016) Yusuke Sasaki et al. Asian Pacific Journal of Cancer Prevention
- Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic review
- (2016) Dario Baratti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial
- (2016) P.H. Cashin et al. EUROPEAN JOURNAL OF CANCER
- Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
- (2016) Jan Franko et al. LANCET ONCOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
- (2013) Jean-Nicolas Vauthey et al. ANNALS OF SURGERY
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases
- (2013) Georgios Karagkounis et al. CANCER
- Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
- (2012) Dario Baratti et al. ANNALS OF SURGERY
- Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
- (2012) J. Segelman et al. BRITISH JOURNAL OF SURGERY
- Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy
- (2012) Y.L.B. Klaver et al. EJSO
- Molecular alterations associated with liver metastases development in colorectal cancer patients
- (2011) S C Bruin et al. BRITISH JOURNAL OF CANCER
- KRAS Status in Patients With Colorectal Cancer Peritoneal Carcinomatosis and Its Impact on Outcome
- (2010) Suzanne M. Gillern et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
- (2010) D. Baratti et al. EJSO
- Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study
- (2010) Valery E. Lemmens et al. INTERNATIONAL JOURNAL OF CANCER
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
- (2009) Dominique Elias et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies
- (2009) Marcello Deraco et al. JOURNAL OF SURGICAL ONCOLOGY
- Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
- (2008) Dominique Elias et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started